Clincosm LogoSign in Get a demo

B-Cell

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphocytic, Chronic Trial run by the NCI (rhIL-15, Obinutuzumab)

Terminated
Has Results
  • Leukemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 11, 2022

Safety of Chlorambucil + Rituximab in CLL Patients

Unknown status
  • CLL
  • +4 more
    • Ascoli Piceno, Italy
    • +19 more
    Mar 21, 2018

    Cancer, Tumors, Lymphoma Trial in Edgbaston, Tremona Road, (Chi Lob 7/4 (A chimeric mAb))

    Completed
    • Cancer
    • +4 more
    • Chi Lob 7/4 (A chimeric monoclonal antibody)
    • Edgbaston, Birmingham, United Kingdom
    • +1 more
    Dec 1, 2014